Question 1

What is Vyzulta 0.024%, solution used for?

Accepted Answer

This medication is prostaglandin analog, prescribed for open angle glaucoma and increased eye pressure, which can lead to a gradual loss of vision.﻿‍‍‍‍‍‍​​​‍​​​​​​﻿ It binds to a specific receptor for prostaglandin, increases the flow of aqueous humor out of the eye, thereby reducing the pressure within the eye and reducing the risk of nerve damage and blindness.

Question 2

What pharmaceutical form is Vyzulta 0.024%, solution available in?

Accepted Answer

Vyzulta 0.024%, solution: 點眼液劑

Question 3

What are the side effects of Vyzulta 0.024%, solution?

Accepted Answer

Heart
-
Chest pain.
Skin
-
Rash/allergic skin reaction.
Eye
-
Latanoprost may affect the eyelids causing redness, swelling, pain, crusting or darkening, eyelashes causing change in hair and misdirecting eyelashes.﻿‍‍‍‍‍‍​​​‍​​​​​​﻿  Besides, it may also cause eye inflammation, damage to the cornea, iris and retina.  The medication may cause symptoms like blurring of vision, increased dryness, redness, pain, foreign body sensation and itching.
Respiratory
-
Upper respiratory tract infection,

Question 4

Can Vyzulta 0.024%, solution be used during pregnancy?

Accepted Answer

•	Do not use within 5 min of thiomersal-containing preparations.
Caution needed for patients with history of aphakia (absence of lens of the eye) or pseudophakia with tor﻿‍‍‍‍‍‍​​​‍​​​​​​﻿n posterior lens cap or anterior chamber lenses, risk factors for cystoid macular oedema, brittle or severe asthma, history of intraocular inflammation, neovascular, angle-closure or congenital glaucoma, during pregnancy and breastfeeding.
•  It may cause blurred vision, do not drive a car or operate machinery

Question 5

What precautions should be taken with Vyzulta 0.024%, solution?

Accepted Answer

•	Do not use within 5 min of thiomersal-containing preparations.
Caution needed for patients with history of aphakia (absence of lens of the eye) or pseudophakia with tor﻿‍‍‍‍‍‍​​​‍​​​​​​﻿n posterior lens cap or anterior chamber lenses, risk factors for cystoid macular oedema, brittle or severe asthma, history of intraocular inflammation, neovascular, angle-closure or congenital glaucoma, during pregnancy and breastfeeding.
•  It may cause blurred vision, do not drive a car or operate machinery

Question 6

What ATC class does Vyzulta 0.024%, solution belong to?

Accepted Answer

Vyzulta 0.024%, solution: ATC S01EE01. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

Vyzulta 0.024%, solution

User Reviews